{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T12:34:02Z","timestamp":1795005242838,"version":"4.9.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Fumarate hydratase tumor predisposition syndrome (FHTPS) is caused by germline fumarate hydratase (FH) pathogenic variants (PVs). Most women with FHTPS develop FH-deficient (FHD) uterine leiomyomas (ULs), which arise 10 to 15 years earlier than aggressive FHD\u2013renal cell carcinoma. We evaluate a previously proposed FHTPS screening strategy for women with ULs. This 5-year, prospective and retrospective study performed FH and later S-(2-succino) cysteine immunohistochemistry (IHC) on all uterine smooth muscle (USM) tumors in patients 40 (later \u226430) years or younger and on all USM tumors with suggestive FHD morphology regardless of age. Patients with FHD tumors by IHC were referred to genetic counseling. Of 840 USM tumors, 112 FHD-tumors by IHC (13%) were identified, all with suggestive FHD-morphology; 44 patients (39%) underwent germline testing, and 15 harbored germline <jats:italic toggle=\"yes\">FH<\/jats:italic> PVs (34.1% of germline tested, 13.4% of all FHD-tumors). While FHD tumors were seen across a wide age range (24 to 73 y), those with germline FH PVs were significantly younger (median 33 vs 44 years wild-type, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0032). Few (12.5%) patients \u226540 and no patients \u226550 had a germline FH PV, whereas a majority (60%) of patients &lt;40 (86% of those &lt;30) had a germline FH PV. We demonstrate that previously proposed resource-conscious screening involving morphology and IHC is effective for identifying women with FHTPS. We provide prospective data confirming patients presenting with FHD-ULs over age 50 are unlikely to harbor germline FH PVs and argue that for germline testing without consideration of other factors, a threshold of younger than 50 years may be appropriate.<\/jats:p>","DOI":"10.1097\/pas.0000000000002362","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:00:10Z","timestamp":1737435610000},"page":"315-327","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Prospective Fumarate Hydratase Tumor Predisposition Syndrome Screening in Patients With Uterine Smooth Muscle Tumors"],"prefix":"10.1097","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8053-5192","authenticated-orcid":false,"given":"Austin","family":"McHenry","sequence":"first","affiliation":[{"name":"Department of Pathology, School of Medicine, Stanford University, Stanford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Monsrud","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Stanford University, Stanford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pors","sequence":"additional","affiliation":[{"name":"Department of Cancer Genetics and Genomics, Stanford Health Care, Palo Alto, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Folkins","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Stanford University, Stanford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri","family":"Longacre","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Stanford University, Stanford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hodan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"R1-20250722","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ajhg.2024.07.019","article-title":"Implementation of a dyadic nomenclature for monogenic diseases","volume":"111","author":"Thaxton","year":"2024","journal-title":"Am J Hum Genet"},{"key":"R2-20250722","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"R3-20250722","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/cge.13222","article-title":"Correction to: reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers","volume":"93","author":"Muller","year":"2018","journal-title":"Clin Genet"},{"key":"R4-20250722","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/PAP.0000000000000423","article-title":"Contemporary updates on sex cord-stromal tumors of the testis","volume":"31","author":"Acosta","year":"2024","journal-title":"Adv Anat Pathol"},{"key":"R5-20250722","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/cup.12396","article-title":"Fumarate hydratase immunohistochemical staining may help to identify patients with multiple cutaneous and uterine leiomyomatosis (MCUL) and hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome","volume":"41","author":"Llamas-Velasco","year":"2014","journal-title":"J Cutan Pathol"},{"key":"R6-20250722","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R7-20250722","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0000000000001372","article-title":"A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients","volume":"44","author":"Lau","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R8-20250722","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment","volume":"13","author":"Menko","year":"2014","journal-title":"Fam Cancer"},{"key":"R9-20250722","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jmg.2005.033506","article-title":"Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer","volume":"43","author":"Wei","year":"2006","journal-title":"J Med Genet"},{"key":"R10-20250722","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","article-title":"Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis","volume":"79","author":"Smit","year":"2011","journal-title":"Clin Genet"},{"key":"R11-20250722","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R12-20250722","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/aogs.14248","article-title":"Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome can be identified through distinct clinical characteristics and typical morphology","volume":"100","author":"Uimari","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R13-20250722","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R14-20250722","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/s41379-020-0596-y","article-title":"Targeted sequencing of FH-deficient uterine leiomyomas reveals biallelic inactivating somatic fumarase variants and allows characterization of missense variants","volume":"33","author":"Popp","year":"2020","journal-title":"Mod Pathol"},{"key":"R15-20250722","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R16-20250722","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10689-021-00272-y","article-title":"Uterine leiomyomatosis in adolescents and young adults (AYAs) may represent a narrow phenotypic variant of FH tumour predisposition syndrome","volume":"21","author":"Foo","year":"2022","journal-title":"Fam Cancer"},{"key":"R17-20250722","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archderm.141.2.199","article-title":"Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome","volume":"141","author":"Alam","year":"2005","journal-title":"Arch Dermatol"},{"key":"R18-20250722","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/PAS.0000000000000520","article-title":"Morphology and immunohistochemistry for 2SC and FH aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients","volume":"39","author":"Joseph","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R19-20250722","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00428-018-2292-6","article-title":"Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening","volume":"472","author":"Siegler","year":"2018","journal-title":"Virchows Arch"},{"key":"R20-20250722","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PAS.0b013e31825ec16f","article-title":"Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome","volume":"37","author":"Sanz-Ortega","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R21-20250722","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PGP.0000000000000091","article-title":"Current morphologic criteria perform poorly in identifying hereditary leiomyomatosis and renal cell carcinoma syndrome-associated uterine leiomyomas","volume":"33","author":"Alsolami","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R22-20250722","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/PAS.0000000000000703","article-title":"Fumarase-deficient uterine leiomyomas: an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases","volume":"40","author":"Miettinen","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R23-20250722","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/PAS.0000000000001222","article-title":"Prospective Detection of germline mutation of fumarate hydratase in women with uterine smooth muscle tumors using pathology-based screening to trigger genetic counseling for hereditary leiomyomatosis renal cell carcinoma syndrome: a 5-year single institutional experience","volume":"43","author":"Rabban","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R24-20250722","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/PAS.0000000000001293","article-title":"Detailed morphologic and immunohistochemical characterization of myomectomy and hysterectomy specimens from women with hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC)","volume":"43","author":"Chan","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R25-20250722","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/PAS.0000000000000626","article-title":"Immunohistochemistry for 2-succinocysteine (2SC) and fumarate hydratase (FH) in cutaneous leiomyomas may aid in identification of patients with FHTPS (hereditary leiomyomatosis and renal cell carcinoma syndrome)","volume":"40","author":"Buelow","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R26-20250722","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.humpath.2022.12.013","article-title":"Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma","volume":"134","author":"Mannan","year":"2023","journal-title":"Hum Pathol"},{"key":"R27-20250722","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and FHTPS patients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J Pathol"},{"key":"R28-20250722","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/his.14007","article-title":"Prevalence of somatic and germline mutations of fumarate hydratase in uterine leiomyomas from young patients","volume":"76","author":"Liu","year":"2020","journal-title":"Histopathology"},{"key":"R30-20250722","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00428-015-1783-y","article-title":"Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC)","volume":"467","author":"Mart\u00ednek","year":"2015","journal-title":"Virchows Arch"},{"key":"R31-20250722","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/gcc.22905","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening","volume":"60","author":"Garg","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"R32-20250722","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.23900","article-title":"Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma","volume":"41","author":"Zhang","year":"2020","journal-title":"Hum Mutat"},{"key":"R33-20250722","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","article-title":"Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics","volume":"10","author":"Lehtonen","year":"2011","journal-title":"Fam Cancer"},{"key":"R34-20250722","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/PAS.0000000000001826","article-title":"Comparison of 2SC, AKR1B10, and FH antibodies as potential biomarkers for FH-deficient uterine leiomyomas","volume":"46","author":"Ahvenainen","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R35-20250722","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/DAD.0000000000000580","article-title":"Loss of fumarate hydratase and aberrant protein succination detected with S-(2-succino)-cysteine staining to identify patients with multiple cutaneous and uterine leiomyomatosis and hereditary leiomyomatosis and renal cell cancer syndrome","volume":"38","author":"Llamas-Velasco","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"R36-20250722","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PGP.0000000000000918","article-title":"Fumarate hydratase and s-(2-succinyl)-cysteine immunohistochemistry shows evidence of fumarate hydratase deficiency in 2% of uterine leiomyosarcomas: a cohort study of 348 tumors","volume":"42","author":"Chapel","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"R37-20250722","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s004280000207","article-title":"Benign metastasizing leiomyoma of the uterus: documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases","volume":"437","author":"Kayser","year":"2000","journal-title":"Virchows Arch"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T08:00:28Z","timestamp":1753171228000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002362"}},"subtitle":["Age, Morphology, Fumarate Hydratase\/S-(2-succino) Cysteine Immunohistochemistry, and Germline Testing"],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002362","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]}}}